HTLV-I in northeast Brazil: Differences for male and female injecting drug users

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 19, Issue 4, 1998, Pages 426-429

  Dourado, Inês ^a   Andrade, Tarcísio ^a   Galvão Castro, Bernardo ^b  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

HIV 1; HTLV I II; Injecting drug use; Snowball sampling

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; DEMOGRAPHY; DISEASE ASSOCIATION; DRUG ABUSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNOBLOTTING; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEROPREVALENCE; SEX DIFFERENCE; SEXUAL BEHAVIOR; STATISTICAL ANALYSIS; SYPHILIS;

EID: 0032402254     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199812010-00016     Document Type: Article

References (18)

1. Tedder RS, Shanson DC, Jeffries DJ, et al. Low prevalence in the UK of HTLV-I and HTLV-II in subjects with AIDS, with extended lymphadenopathy, and at risk of AIDS. Lancet 1984;2:125-8.
2. Lee HH, Weiss SH, Brown LS, Mildvan D, et al. Patterns of HIV-1 and HTLV-I/II in intravenous drug abusers from the Middle Atlantic and Central Regions of the USA. J Infect Dis 1990;162:347-52.
3. Lee H, Swanson P, Shorty VS, Zack JA, Rosenblatt JD, Chen IS. High rate of HTLV-II infection in seropositive intravenous drug users in New Orleans. Science 1989;244:471-5.
4. Khabbaz RF, Onorato IM, Cannon RO, et al. Seroprevalence of HTLV-I and HTLV-II among intravenous drug users and persons in clinics for sexually transmitted diseases. N Engl J Med 1990; 326:375-80.
5. Feigal E. Human T cell lymphotropic virus types I and II in intravenous drug users in San Francisco: risk factors associated with seropositivity. J Infect Dis 1991;164;36-42.
6. Briggs NC, Battjes RJ, Cantor KP, et al. Seroprevalence of human T cell lymphotropic virus types II infection, with and without human immunodeficiency virus type 1 coinfection, among US intravenous drug users. J Infect Dis 1995;172:51-8.
7. Pombo de Oliveira MS, Matutes E, Famadas LC, et al. Adult T-cell leukemia/lymphoma in Brazil and its relation to HTLV-I. Lancet 1990;1:45-8.
8. Gabbai AA, Bordin JO, Vieira-Filho JBP, et al. Selectivity of human T-lymphotropic virus type-I (HTLV-I) and HTLV-II infection among different populations in Brazil. Am J Trop Med Hyg 1993;49:664-71.
9. Araujo AQC, Andrada-Serpa MJ. Tropical spastic paraparesis/ HTLV-I associated myelopathy in Brazil. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13(suppl):S33-6.
10. Galvão-Castro B, Loures L, Rodrigues L, et al. Distribution of human T-cell lymphotropic virus type I among blood donors: a nationwide Brazilian study. Transfusion 1997;37:42.
11. Moreira ED, Ribeiro, TT, Swanson P, et al. Seroepidemiology of HTLV type I/II in Northeastern Brazil. J Acquir Immune Defic Syndr 1993;6:959-63.
12. Araujo CA, Casseb JSR, Neitzert E, et al. HTLV-I and HTLV-II infections among HIV-1 seropositive patients in São Paulo, Brazil. Eur J Epidemiol 1994;10:165-71.
13. de Carvalho HB, Mesquita F, Massad E, et al. HIV and infections of similar transmission patterns in drug injectors community of Santos, Brazil. J Acquir Immune Defic Syndr Hum Retrovirol 1996;12:84-92.
14. Bellei NCJ, Granato CFH, Tomyana H, Castelo A, Ferreira O. HTLV infection in a group of prostitutes and their male sexual clients in Brazil: seroprevalence and risk factors. Trans R Soc Trop Med Hyg 1996;90:122-5.
15. Andrade TM, Dourado I, Galvão-Castro B. Associations among HTLV-I, HTLV-II, and HIV in injecting drug users in Salvador, Brazil. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18: 186-7.
16. Biernack P, Walford D. Snowball sampling: problems and techniques of chain referral sampling. Social Methods Res 1981;2:141-63.
17. Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: the prevalence of hepatitis C, hepatitis B. human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health 1996;86:655-61.
18. Nicolosi A, Leite MLC, Musicco M, Molinari S, Lazarrin A. Parental and sexual transmission of human immunodeficiency virus in intravenous drug users: a study of seroconversion. Am J Epidemiol 1992;135:225-33.